KES
Articles
- Page Path
- HOME > Endocrinol Metab > Volume 22(2); 2007 > Article
- Case Report Two Cases of Acromegaly with Empty Sella Syndrome Treated by Long-Acting Release Octreotide.
- Dong Jin Kim, Young Jin Seo, Nam Hoon Kim, Hye Soo Chung, Chai Ryoung Eun, Hye Jung Choi, Hye Sook Kim, Sae Jeong Yang, Juri Park, Hye Jin Yoo, Soo Yeon Park, Yun Jeong Lee, Ohk Hyun Ryu, Kye Won Lee, Hee Young Kim, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi
-
Endocrinology and Metabolism 2007;22(2):135-141
DOI: https://doi.org/10.3803/jkes.2007.22.2.135
Published online: April 1, 2007
- 2,346 Views
- 30 Download
- 0 Crossref
- 0 Scopus
Department of Internal Medicine, Korea University College of Medicine, Korea.
Abstract
Two cases of typical acromegaly with empty sella syndrome presented to our institution. In the natural course of untreated pituitary adenoma, empty sella syndrome may result from necrosis by infarction or from hemorrhage of the pituitary gland. In our patients, the secretion of growth hormone continued in spite of the existence of empty sella syndrome. In one case, we confirmed the hypersecretion of growth hormone from sella by jugular vein sampling. Medical therapy with somatostatin analogue was attempted because there was no obvious mass in the sella. After 6~12 months of treatment with long-acting release octreotide, clinical features in our patients were improved, and the level of growth hormone and IGF-1 were also normalized.
Cite- Related articles
-
